SEARCH

SEARCH BY CITATION

REFERENCES

  • Abraham W.M., Sielczak M.W., Ahmed A. et al. (1994) Alpha 4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep. J Clin Invest 93:77687.
  • Abu Ghazaleh R., Fujisawa T., Mestecky J., Kyle R.A., & Gleich G.J. (1989) IgA-induced eosinophil degranulation. J Immunol 142:2393400.
  • Ackerman S.J., Kephart G.M., Habermann T.M., Greipp P.R., & Gleich G.J. (1983) Localization of eosinophil granule major basic protein in human basophils. J Exp Med 158:94661.
  • Ackerman S.J., Gleich G.J., Loegering D.A., Richardson B.A., & Butterworth A.E. (1985) Comparative toxicity of purified human eosinophil granule cationic proteins for schistosomula of Schistosoma mansoni. Am J Trop Med Hyg 34:73545.
  • Ackerman S.J., Liu L., Kwatia M.A. et al. (2002) Charcot–Leyden crystal protein (galectin-10) is not a dual function galectin with lysophospholipase activity but binds a lysophospholipase inhibitor in a novel structural fashion. J Biol Chem 277:1485968.
  • Adamko D.J., Yost B.L., Gleich G.J., Fryer A.D., & Jacoby D.B. (1999) Ovalbumin sensitization changes the inflammatory response to subsequent parainfluenza infection: eosinophils mediate airway hyperresponsiveness, M2 muscarinic receptor dysfunction and antiviral effects. J Exp Med 1999:146577.
  • Adamko D.J., Yost B.L., Gleich G.J., Fryer A.D., & Jacoby D.B. (2001) Antiviral activity of eosinophil peroxidase mediated via sodium bromide. Abstract 018, International Meeting of the Eosinophil Society, May 3–6, 2001, Banff, Alberta, Canada.
  • Advani R.J., Yang B., Prekeris R., Lee K.C., Klumperman J., & Scheller R.H. (1999) VAMP-7 mediates vesicular transport from endosomes to lysosomes. J Cell Biol 146:76576.
  • Aldebert D., Lamkhioued B., Desaint C. et al. (1996) Eosinophils express a functional receptor for interferon alpha: inhibitory role of interferon alpha on the release of mediators. Blood 87:235460.
  • Anderson R.E., & Hardy W.R. (1968) Hypereosinophilia. Ann Intern Med 69:13312.
  • Andy J.J., Ogunowo P.O., Akpan N.A., Odigwe C.O., Ekanem I.A., & Esin R.A. (1998) Helminth associated hypereosinophilia and tropical endomyocardial fibrosis (EMF) in Nigeria. Acta Trop 69:12740.
  • Ault P., Cortes J., Koller C., Kaled E.S., & Kantarjian H. (2002) Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate. Leuk Res 26:8814.
  • Bandeira-Melo C., Bozza P.T., Diaz B.L. et al. (2000) Cutting edge: lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4 block allergeninduced eosinophil trafficking. J Immunol 164:226771.
  • Bandeira-Melo C., Woods L.J., Phoofolo M., & Weller P.F. (2002a) Intracrine cysteinyl leukotriene receptor-mediated signaling of eosinophil vesicular transport-mediated interleukin-4 secretion. J Exp Med 196:84150.
  • Bandeira-Melo C., Hall J.C., Penrose J.F., & Weller P.F. (2002b) Cysteinyl leukotrienes induce IL-4 release from cord blood-derived human eosinophils. J Allergy Clin Immunol 109:9759.
  • Bankers-Fulbright J.L., Kephart G.M., Loegering D.A. et al. (1998) Sulfonylureas inhibit cytokine-induced eosinophil survival and activation. J Immunol 160:554653.
  • Barbato A., Turato G., Baraldo S. et al. (2006) Epithelial damages and angiogenesis in the airways of children with asthma. Am J Respir Cell Mol Biol 35:37886.
  • Barends M., De Rond L.G., Dormans J. et al. (2004) Respiratory syncytial virus, pneumonia virus of mice, and influenza A virus differently affect respiratory allergy in mice. Clin Exp Allergy 34:48896.
  • Barker R.L., Gleich G.J., & Pease L.R. (1988) Acidic precursor revealed in human eosinophil granule major basic protein cDNA. J Exp Med 168:14938 [Erratum appears in J Exp Med (1989) 170, 1057.].
  • Barker R.L., Loegering D.A., Ten R.M., Hamann K.J., Pease L.R., & Gleich G.J. (1989) Eosinophil cationic protein cDNA. Comparison with other toxic cationic proteins and ribonucleases. J Immunol 143:9525.
  • Barnes P.J., & Adcock I.M. (1995) Steroid resistance in asthma. Q J Med 88:45568.
  • Barthel S.R., Jarjour N.N., Mosher D.F., & Johnansson M.W. (2006) Dissection of the hyperadhesive phenotype of airway eosinophils in asthma. Am J Respir Cell Mol Biol 35:37886.
  • Bazan-Socha S., Bukiej A., Pulka G., Marcinkiewicz C., & Musial J. (2006) Increased expression of collagen receptors: a1b1 and a2b1 integrins on blood eosinophils in bronchial asthma. Clin Exp Allergy 36:118491.
  • Behm C.A., & Ovington K.S. (2000) The role of eosinophils in parasitic helminth infections: insights from genetically modified mice. Parasitol Today 16:2029.
  • Bel E.H. (2004) Clinical phenotypes of asthma. Curr Opin Pulm Med 10:4450.
  • Benayoun L., Druilhe A., Dombret M.C., Aubier M., & Pretolani M. (2003) Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med 167:13608.
  • Berg E.L., McEvoy L.M., Berlin C., Bargatze R.F., & Butcher E.C. (1993) L-selectin-mediated lymphocyte rolling on MAdCAM-1. Nature 366:6958.
  • Bischoff S.C. (1996) Mucosal allergy: role of mast cells and eosinophil granulocytes in the gut. Baillieres Clin Gastroenterol 10:44359.
  • Blanchard C., Mishra A., Saito-Akei H., Monk P., Anderson I., & Rothenberg M.E. (2005) Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by antihuman-interleukin-13 antibody (CAT-354). Clin Exp Allergy 35:1096103.
  • Blanchard C., Wang N., Stringer K.F. et al. (2006) Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 116:53647.
  • Bochner B.S., & Busse W.W. (2005) Allergy and asthma. J Allergy Clin Immunol 115:9539.
  • Bochner B.S., & Schleimer R.P. (1994) The role of adhesion molecules in human eosinophil and basophil recruitment. J Allergy Clin Immunol 94:42738.
  • Bochner B.S., & Schleimer R.P. (2001) Mast cells, basophils and eosinophils: distinct but overlapping pathways for recruitment. Immunol Rev 179:515.
  • Bousquet J., Jeffery P., Busse W., Johnson M., & Vignola A. (1990) Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 161:172045.
  • Boyce J.A., Friend D., Matsumoto R., Austen K.F., & Owen W.F. (1995) Differentiation in vitro of hybrid eosinophil/basophil granulocytes: autocrine function of an eosinophil developmental intermediate. J Exp Med 182:4957.
  • Brightling C.E., Bradding P., Symon F.A., Holgate S.T., Wardlaw A.J., & Pavord I.D. (2002) Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 346:1699705.
  • Brightling C.E., Symon F.A., Birring S.S., Bradding P., Wardlaw A.J., & Pavord I.D. (2003) Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax 58:52832.
  • Brottman G.M., Regelmann W.E., Slungaard A., & Wangensteen O.D. (1996) Effect of eosinophil peroxidase on airway epithelial permeability in the guinea pig. Pediatr Pulmonol 21:15966.
  • Brown L.F., Goldman H., & Antonioli D.A. (1984) Intraepithelial eosinophils in endoscopic biopsies of adults with reflux esophagitis. Am J Surg Pathol 8:899905.
  • Brusasco V., Crimi E., Gianiorio P., Lantero S., & Rossi G.A. (1990) Allergen-induced increase in airway responsiveness and inflammation in mild asthma. J Appl Physiol 69:220914.
  • Bullock E.D., Johnson E.M. Jr (1996) Nerve growth factor induces the expression of certain cytokine genes and bcl-2 in mast cells. Potential role in survival promotion. J Biol Chem 271:275008.
  • Butterworth A.E. (1984) Cell-mediated damage to helminths. Adv Parasitol 23:143235.
  • Butterworth A.E., Franks D. (1975) Nonspecific cytotoxic effects of antigen-transformed lymphocytes. III. Relationship to specific cytotoxicity. Cell Immunol 16:7481.
  • Caldwell J.H., Tennerbaum J.I., Bronstein H.A. (1975) Serum IgE to eosinophilic gastroenteritis. N Engl J Med 292:138890.
  • Capron M., Kusnierz J.P., Prin L. et al. (1985) Cytophilic IgE on human blood and tissue eosinophils: detection by flow micro-fluorometry. J Immunol 134:30138.
  • Capron M., Soussi Gounni A., Morita M. et al. (1995) Eosinophils: from low- to high-affinity immunoglobulin E receptors. Allergy 50 (25 suppl.):203.
  • Cardenas S., Auais A., & Piedimonte G. (2005) Palivizumab in the prophylaxis of respiratory syncytial virus infection. Expert Rev Anti Infect Ther 3:71926.
  • Cello J.P. (1979) Eosinophilic gastroenteritis: a complex disease entity. Am J Med 67:1097114.
  • Chae S.C., Park Y.R., Oh G.J., Lee J.H., & Chung H.T. (2005) The suggestive association of eotaxin-2 and eotaxin-3 gene polymorphisms in Korean population with allergic rhinitis. Immunogenetics 56:7604.
  • Cho J.Y., Miller M., Baek K.J. et al. (2004) Inhibition of airway remodeling in IL-5 deficient mice. J Clin Invest 113:55160.
  • Chusid M.J., Dale D.C., West B.C., & Wolff S.M. (1975) The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 54:127.
  • Clark K., Simson L., Newcombe N. et al. (2004) Eosinophil degranulation in the allergic lung of mice primarily occurs in the airway lumen. J Leukoc Biol 75:10019.
  • Cockcroft D.W., Ruffin R.E., Dolovich J., & Hargreave F.E. (1977) Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy 7:50313.
  • Coffman R.L., Seymour B.W., Hudak S., Jackson J., & Rennick D. (1989) Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 245:30810.
  • Collins P.D., Marleau S., Griffiths-Johnson D.A., Jose P.J., & Williams T.J. (1995) Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 182:116974.
  • Cools J., DeAngelo D.J., Gotlib J. et al. (2003) A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348:120114.
  • Cools J., Quentmeier H., Huntly B.J. et al. (2004a) The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia. Blood 103:28025.
  • Cools J., Stover E.H., Wlodarska I., Marynen P., & Gilliland D.G. (2004b) The FIP1L1-PDGFRalpha kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia. Curr Opin Hematol 11:517.
  • Cortes J., Ault P., Koller C. et al. (2003) Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome. Blood 101:471416.
  • Coyle A.J., Ackerman S.J., & Irvin C.G. (1993) Cationic proteins induce airway hyperresponsiveness dependent on charge interactions. Am Rev Respir Dis 147:896900.
  • Crimi E., Spanevello A., Neri M., Ind P.W., Rossi G.A., & Brusasco V. (1998) Dissociation between airway inflammation and airway responsiveness in allergic asthma. Am J Respir Crit Care Med 157:49.
  • Cromwell O., Moqbel R., Fitzharris P. et al. (1988) Leukotriene C4 generation from human eosinophils stimulated with IgG–Aspergillus fumigatus antigen immune complexes. J Allergy Clin Immunol 82:53543.
  • Cromwell O., Wardlaw A.J., Champion A., Moqbel R., Osei D., & Kay A.B. (1990) IgG-dependent generation of platelet-activating factor by normal and low density human eosinophils. J Immunol 145:38628.
  • Culley F.J., Pollott J., & Openshaw P.J. (2002) Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood. J Exp Med 196:13816.
  • Daffern P.J., Pfiefer P.H., Ember J.A., & Hugli T.E. (1995) C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J Exp Med 181:211927.
  • Daugherty B.L., Siciliano S.J., Demartino J.A., Malkowitz L., Sirotina A., & Springer M.S. (1996) Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J Exp Med 183:234954.
  • Davis M.D., Plager D.A., George T.J., Weiss E.A., Gleich G.J., & Leiferman K.M. (2003) Interactions of eosinophil granule proteins with skin: limits of detection, persistence, and vasopermeabilization. J Allergy Clin Immunol 112:98894.
  • Dehlawi M.S., & Goyal P.K. (2003) Responses of inbred mouse strains to infection with intestinal nematodes. J Helminthol 77:11924.
  • De Jesus A.R., Magalhaes A., Miranda D.G. et al. (2004) Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection. Infect Immun 72:33917.
  • De Koter R.P., & Singh H. (2000) Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science 288:143941.
  • Dent L.A., Strath M., Mellor A.L., & Sanderson C.J. (1990) Eosinophilia in transgenic mice expressing interleukin 5. J Exp Med 172:142531.
  • Denzler K.L., Borchers M.T., Crosby J.R. et al. (2001) Extensive eosinophil degranulation and peroxidase-mediated oxidation of airway proteins do not occur in a mouse ovalbumin-challenge model of pulmonary inflammation. J Immunol 167:167282.
  • Desreumaux P., Nutten S., & Colombel J.F. (1999) Activated eosinophils in inflammatory bowel disease: do they matter? Am J Gastroenterol 94:33968.
  • DeVincenzo J.P. (2005) Factors predicting childhood respiratory syncytial virus severity: what they indicate about pathogenesis. Pediatr Infect Dis J 24:S177S183.
  • Dimova-Yaneva D., Russell D., Main M., Brooker R.J., & Helms P.J. (2004) Eosinophil activation and cysteinyl leukotriene production in infants with respiratory syncytial virus bronchiolitis. Clin Exp Allergy 34:5558.
  • DiScipio R.G., Daffern P.J., Jagels M.A., Broide D.H., & Sriramarao P. (1999) A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo. J Immunol 162:112736.
  • Djukanovic R., Wilson J.W., Britten K.M. et al. (1990) Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis 142:86371.
  • Domachowske J.B., Dyer K.D., Bonville C.A., & Rosenberg H.F. (1998) Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus. J Infect Dis 177:145864.
  • Domachowske J.B., Bonville C.A., Dyer K.D., Easton A.J., & Rosenberg H.F. (2000a) Pulmonary eosinophilia and production of MIP-1alpha are prominent responses to infection with pneumonia virus of mice. Cell Immunol 200:98104.
  • Domachowske J.B., Bonville C.A., Gao J.L., Murphy P.M., Easton A.J., & Rosenberg H.F. (2000b) The chemokine MIP-1α and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection. J Immunol 165:267782.
  • Dorman S.C., Sehmi R., Gauvreau G.M. et al. (2004a) Kinetics of bone marrow eosinophilopoiesis and associated cytokines after allergen inhalation. Am J Respir Crit Care Med 169:56572.
  • Dorman S.C., Efthimiadis A., Babirad I. et al. (2004b) Sputum CD34+IL-5Ralpha+ cells increase after allergen: evidence for in situ eosinophilopoiesis. Am J Respir Crit Care Med 169:5737.
  • Douwes J., Gibson P., Pekkanen J., & Pearce N. (2002) Noneosinophilic asthma: importance and possible mechanisms. Thorax 57:6438.
  • Du J., Stankiewicz M.J., Liu Y. et al. (2002) Novel combinatorial interactions of GATA-1, PU.1, and C/EBPepsilon isoforms regulate transcription of the gene encoding eosinophil granule major basic protein. J Biol Chem 277:4348194.
  • Dubois G.R., Schweizer R.C., Versluis C., Bruijnzeel-Koomen C.A., & Bruijnzeel P.L. (1998) Human eosinophils constitutively express a functional interleukin-4 receptor: interleukin-4-induced priming of chemotactic responses and induction of PI-3 kinase activity. Am J Respir Cell Mol Biol 19:6919.
  • Durack D.T., Sumi S.M., & Klebanoff S.J. (1979) Neurotoxicity of human eosinophils. Proc Natl Acad Sci USA 76:14437.
  • Durcan N., Costello R.W., McLean W.G. et al. (2006) Eosinophilmediated cholinergic nerve remodelling. Am J Respir Cell Mol Biol 34:77586.
  • Dvorak A.M. (1980) Ultrastructural evidence for release of major basic protein-containing crystalline cores of eosinophil granules in vitro: cytotoxic potential in Crohn's disease. J Immunol 125:4602.
  • Easton A.J., Domachowske J.B., & Rosenberg H.F. (2007) Pneumonia virus of mice. In: CaneP., ed. Perspectives in Medical Virology, XXXX, XXXX, pp. 299319.
  • Ebisawa M., Schleimer R.P., Bickel C., & Bochner B.S. (1995) Phenotyping of purified human peripheral blood eosinophils using the blind panel mab. In: SchlossmanS.F., BoumsellL., GilksW. et al. eds. Leukocyte Typing V: White Cell Differentiation Antigens. Oxford University Press, New York. pp. 10368.
  • Ebnet K., Kaldjian E.P., Anderson A.O., & Shaw S. (1996) Orchestrated information transfer underlying leukocyte endothelial interactions. Annu Rev Immunol 14:15577.
  • Egan R.W., Athwahl D., Chou C.C. et al. (1995) Inhibition of pulmonary eosinophilia and hyperreactivity by antibodies to interleukin-5. Int Arch Allergy Appl Immunol 107:3212.
  • Egesten A., Alumets J., Von Mecklenburg C., Palmegren M., & Olsson I. (1986) Localization of eosinophil cationic protein, major basic protein, and eosinophil peroxidase in human eosinophils by immunoelectron microscopic technique. J Histochem Cytochem 34:1399403.
  • Elsner J., Petering H., Hochstetter R. et al. (1997) The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3. Eur J Immunol 27:28928.
  • Elsner J., Petering H., Kimmig D., Wells T.N., Proudfoot A.E., & Kapp A. (1999) The CC chemokine receptor antagonist met-RANTES inhibits eosinophil effector functions. Int Arch Allergy Immunol 118:4625.
  • Elsner J., Dulkys Y., Gupta S. et al. (2005) Differential pattern of CCR1 internalization in human eosinophils: prolonged internalization by CCL5 in contrast to CCL3. Allergy 60:138693.
  • Evans C.M., Fryer A.D., Jacoby D.B., Gleich G.J., & Costello R.W. (1997) Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. J Clin Invest 100:225462.
  • Everard M.L. (2006) The role of the respiratory syncytial virus in airway syndromes in childhood. Curr Allergy Asthma Rep 6:97102.
  • Feng D., Flaumenhaft R., Bandeira-Melo C., Weller P., & Dvorak A. (2001) Ultrastructural localization of vesicle-associated membrane protein(s) to specialized membrane structures in human pericytes, vascular smooth muscle cells, endothelial cells, neutrophils, and eosinophils. J Histochem Cytochem 49:293304.
  • Fischer E., Capron M., Prin L., Kusnierz J.P., & Kazatchkine M.D. (1986) Human eosinophils express CR1 and CR3 complement receptors for cleavage fragments of C3. Cell Immunol 97:297306.
  • Flood-Page P., Menzies-Gow A., Phipps S. et al. (2002) Reduction of tissue eosinophils in mild atopic asthmatics by an anti-IL-5 monoclonal antibody (mepolizumab) is associated with inhibition of tenascin deposition within the bronchial epithelium basement membrane. Am J Respir Crit Care Med 109:165.
  • Flood-Page P., Phipps S., Menzies-Gow A., Ong Y.E., & Kay A.B. (2003a) Effect of intravenous administration of an anti-IL-5 (mepolizumab) on allergen-induced tissue eosinophilia, the latephase allergic reaction and the expression of a marker of repair/remodeling in human atopic subjects. J Allergy Clin Immunol 111:S261.
  • Flood-Page P.T., Menzies-Gow A.N., Kay A.B., & Robinson D.S. (2003b) Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 167:199204.
  • Flood-Page P., Menzies-Gow A., Phipps S. et al. (2003c) Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 112:102936.
  • Forbes E., Hulett M., Ahrens R. et al. (2006) ICAM-1-dependent pathways regulate colonic eosinophilic inflammation. J Leukoc Biol 80:33041.
  • Foster B., Percopo M., Lee N.A. et al. (2007) Differential recruitment and activation of NK cells in wild type and ΔdblGATA eosinophil lineage-ablated mice. (In review).
  • Foster P., Hogan S., Ramsay A., Matthaei K., & Young I. (1996) Interleukin-5 deficiency abolishes eosinophilia, airway hyperreactivityand lung damage in mouse asthma model. J Exp Med 183:195201.
  • Foster P., Mould A., Yang M. et al. (2001) Elemental signals regulating eosinophil accumulation in the lung. Immunol Rev 179:17381.
  • Fox V.L., Nurko S., & Furuta G.T. (2002) Eosinophilic esophagitis. Gastrointest Endosc 56:26070.
  • Fredens K., Dahl R., & Venge P. (1982) The Gordon phenomenon induced by the eosinophil cationic protein and eosinophil protein X. J Allergy Clin Immunol 70:3616.
  • Frigas E., Loegering D.A., & Gleich G.J. (1980) Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. Lab Invest 42:3543.
  • Fryer A.D., Stein L.H., Nie Z. et al. (2006) Neuronal eotaxin and the effects of CCR3 antagonist on airway hyperreactivity and M2 receptor dysfunction. J Clin Invest 116:22836.
  • Fujii M., Tanaka H., & Abe S. (2005) Interferon-gamma up-regulates expression of cysteinyl leukotriene type 2 receptors on eosinophils in asthmatic patients. Chest 128:314855.
  • Fulkerson P.C., Zhu H., Williams D.A., Zimmermann N., & Rothenberg M.E. (2005) CXCL9 inhibits eosinophil responses by a CCR3- and Rac2-dependent mechanism. Blood 106:43643.
  • Furuta G.T. (1998) Eosinophils in the esophagus: acid is not the only cause. J Pediatr Gastroenterol Nutr 26:46871.
  • Furuta G.T., Ackerman S.J., & Wershil B.K. (1995) The role of the eosinophil in gastrointestinal diseases. Curr Opin Gastroenterol 11:5417.
  • Furuta G.T., Nieuwenhuis E.E., Karhausen J. et al. (2005) Eosinophils alter colonic epithelial barrier function: role for major basic protein. Am J Physiol 289:G890G897.
  • Gaddy J.N., Margolskee D.J., Bush R.K., Williams V.C., & Busse W.W. (1992) Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma. Am Rev Respir Dis 146:35863.
  • Galli T., Zahraoui A., Vaidyanathan V.V. et al. (1998) A novel tetanus neurotoxin-insensitive vesicle-associated membrane protein in SNARE complexes of the apical plasma membrane of epithelial cells. Mol Biol Cell 9:143748.
  • Garofalo R., Kimpen J.L., Welliver R.C., & Ogra P.L. (1992) Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J Pediatr 120:2832.
  • Garofalo R.P., Patti J., Hintz K.A., Hill V., Ogra P.L., & Welliver R.C. (2001) Macrophage inflammatory protein-1 alpha (not Thelper 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis. J Infect Dis 184:3939.
  • Garrett J.K., Jameson S.C., Thomson B. et al. (2004) Antiinterleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol 113:11519.
  • Gauthier M.C., Racine C., Ferland C. et al. (2003) Expression of membrane type-4 matrix metalloproteinase (metalloproteinase-17) by human eosinophils. Int J Biochem Cell Biol 35:166773.
  • Gauvreau G.M., Watson R.M., & O'Byrne P.M. (1999) Kinetics of allergen-induced airway eosinophilic cytokine production and airway inflammation. Am J Respir Crit Care Med 160:6407.
  • Georas S.N., Liu M.C., Newman W., Beall L.D., Stealey B.A., & Bochner B.S. (1992) Altered adhesion molecule expression and endothelial cell activation accompany the recruitment of human granulocytes to the lung after segmental antigen challenge. Am J Respir Cell Mol Biol 7:2619.
  • Georas S.N., McIntyre B.W., Ebisawa M. et al. (1993) Expression of a functional laminin receptor (alpha 6 beta 1, very late activation antigen-6) on human eosinophils. Blood 82:28729.
  • Giembycz M.A., & Lindsay M.A. (1999) Pharmacology of the eosinophil. Pharmacol Rev 51:213340.
  • Glauert A.M., & Butterworth A.E. (1977) Morphological evidence for the ability of eosinophils to damage antibody-coated schistosomula. Trans R Soc Trop Med Hyg 71:3925.
  • Gleich G.J., & Adolphson C.R. (1986) The eosinophilic leukocyte: structure and function. Adv Immunol 39:177253.
  • Gleich G.J., & Loegering D.A. (1984) Immunobiology of eosinophils. Annu Rev Immunol 2:42959.
  • Gleich G.J., Loegering D.A., & Maldonado J.E. (1973) Identification of a major basic protein in guinea pig eosinophil granules. J Exp Med 137:145971.
  • Gleich G.J., Loegering D.A., Bell M.P., Checkel J.L., Ackerman S.J., & McKean D.J. (1986) Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. Proc Natl Acad Sci USA 83:314650.
  • Gleich G.J., Leiferman K.M., Pardanani A., Tefferi A., & Butterfield J.H. (2002) Treatment of hypereosinophilic syndrome with imatinib mesilate. Lancet 359:15778.
  • Gombart A.F., Kwok S.H., Anderson K.L., Yamaguchi Y., Torbett B.E., & Koeffler H.P. (2003) Regulation of neutrophil and eosinophil secondary granule gene expression by transcription factors C/EBP epsilon and PU1. Blood 101:326573.
  • Gonzalo J.A., Lloyd C.M., Kremer L. et al. (1996) Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. J Clin Invest 98:233245.
  • Gonzalo J.A., Lloyd C.M., Wen D. et al. (1998) The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J Exp Med 188:15767.
  • Gouon-Evans V., & Pollard J.W. (2001) Eotaxin is required for eosinophil homing into the stroma of the pubertal and cycling uterus. Endocrinology 142:451521.
  • Gouon-Evans V., Rothenberg M.E., & Pollard J.W. (2000) Postnatal mammary gland development requires macrophages and eosinophils. Development 127:226982.
  • Grayson M.H., Van der Vieren M., Sterbinsky S.A. et al. (1998) alphadbeta2 integrin is expressed on human eosinophils and functions as an alternative ligand for vascular cell adhesion molecule 1 (VCAM-1). J Exp Med 188:218791.
  • Green R.H., Brightling C.E., McKenna S. et al. (2002) Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 360:171521.
  • Griffin J.H., Leung J., Bruner R.J., Caligiuri M.A., & Briesewitz R. (2003) Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome. Proc Natl Acad Sci USA 100:78305.
  • Guajardo J.R., Plotnick L.M., Fende J.M., Collins M.H., Putnam P.E., & Rothenberg M.E. (2002) Eosinophil-associated gastrointestinal disorders: a world-wide-web based registry. J Pediatr 141:57681.
  • Gundel R.H., Letts L.G., & Gleich G.J. (1991) Human eosinophil major basic protein induces airways constriction and airway hyperresponsiveness in primates. J Clin Invest 87:14703.
  • Gupta S.K., Ross G.D., Good R.A., & Siegal F.P. (1976) Surface markers of human eosinophils. Blood 48:75563.
  • Guyot B., Valverde-Garduno V., Porcher C., & Vyas P. (2004) Deletion of the major GATA-1 enhancer HS1 does not affect GATA1 expression and eosinophil differentiation. Blood 104:8991.
  • Hagan P., Wilkins H.A., Blumenthal U.J., Hayes R.J., & Greenwood B.M. (1985) Eosinophilia and resistance to Schistosoma haematobium in man. Parasite Immunol 7:62532.
  • Hahn C., Islamian A.P., Renz H., & Nockher A. (2006) Airway epithelial cells produce neutrophins and promote the survival of eosinophils during allergic airway inflammation. J Allergy Clin Immunol 117:78794.
  • Hamann K.J., Barker R.L., Loegering D.A., & Gleich G.J. (1987) Comparative toxicity of purified human eosinophil granule proteins for newborn larvae of Trichinella spiralis. J Parasitol 73:5239.
  • Hamann K.J., Ten R.M., Loegering D.A. et al. (1990) Structure and chromosome localization of the human eosinophil-derived neurotoxin and eosinophil cationic protein genes: evidence for intronless coding sequences in the ribonuclease gene superfamily. Genomics 7:53546.
  • Hamann K.J., Barker R.L., Ten R.M., & Gleich G.J. (1991) The molecular biology of eosinophil granule proteins. Int Arch Allergy Appl Immunol 94:2029.
  • Handzel Z.T., Busse W.W., Sedgwick J.B. et al. (1998) Eosinophils bind rhinovirus and activate virus-specific T cells. J Immunol 160:127984.
  • Hansel T.T., Braunstein J.B., Walker C. et al. (1991) Sputum eosinophils from asthmatics express ICAM-1 and HLA-DR. Clin Exp Immunol 86:2717.
  • Harrison A.M., Bonville C.A., Rosenberg H.F., & Domachowske J.B. (1999) Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation. Am J Respir Crit Care Med 159:191824.
  • Hartnell A., Moqbel R., Walsh G.M., Bradley B., & Kay A.B. (1990) Fc gamma and CD11/CD18 receptor expression on normal density and low density human eosinophils. Immunology 69:26470.
  • Hartnell A., Kay A.B., & Wardlaw A.J. (1992) IFN-γ induces expression of FcγRIII (CD16) on human eosinophils. J Immunol 148:14718.
  • Haselden B.M., Kay A.B., & Larche M. (1999) Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J Exp Med 189:188594.
  • Haskell M.D., Moy J.N., Gleich G.J., & Thomas L.L. (1995) Analysis of signaling events associated with activation of neutrophil superoxide anion production by eosinophil granule major basic protein. Blood 86:462737.
  • Hastie A.T., Loegering D.A., Gleich G.J., & Kueppers F. (1987) The effect of purified human eosinophil major basic protein on mammalian ciliary activity. Am Rev Respir Dis 135:84853.
  • Hauber H.P., Bergeron C., & Hamid Q. (2004) IL-9 in allergic inflammation. Int Arch Allergy Immunol 134:7987.
  • Heil F., Hemmi H., Hochrein H. et al. (2004) Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303:15269.
  • Henderson J.P., Byun J., Williams M.V. et al. (2001) Bromination of deoxycytidine by eosinophil peroxidase: a mechanism for mutagenesis by oxidative damage of nucleotide precursors. Proc Natl Acad Sci USA 98:16316.
  • Herndon F.J., & Kayes S.G. (1992) Depletion of eosinophils by anti-IL-5 monoclonal antibody treatment of mice infected with Trichinella spiralis does not alter parasite burden or immunologic resistance to reinfection. J Immunol 149:36427.
  • Hibi T., Hirashima N., & Nakanishi M. (2000) Rat basophilic leukemia cells express syntaxin-3 and VAMP-7 in granule membranes. Biochem Biophys Res Commun 271:3641.
  • Hill S.M., & Milla P.J. (1990) Colitis caused by food allergy in infants. Arch Dis Child 65:1323.
  • Hirai H., Tanaka K., Yoshie O. et al. (2001) Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 193:25561.
  • Hirai H., Zhang P., Dayaram T. et al. (2006) C/EBPβ, is required for emergency granulopoiesis. Nat Immunol 7:7329.
  • Hirasawa R., Shimizu R., Takahashi S. et al. (2002) Essential and instructive roles of GATA factors in eosinophil development. J Exp Med 195:137986.
  • Hisamatsu K., Ganbo T., Nakazawa T. et al. (1990) Cytotoxicity of human eosinophil granule major basic protein to human nasal sinus mucosa in vitro. J Allergy Clin Immunol 86:5263.
  • Hoffmann H.J., Bjerke T., Karawajczyk M., Dahl R., Knepper M.A., & Nielsen S. (2001) SNARE proteins are critical for regulated exocytosis of ECP from human eosinophils. Biochem Biophys Res Commun 280:1726.
  • Hogan S.P., Koskinen A., & Foster P.S. (1997) Interleukin-5 and eosinophils induce airway damage and bronchial hyperreactivity during allergic airway inflammation in BALB/c mice. Immunol Cell Biol 75:2848.
  • Hogan S.P., Mishra A., Brandt E.B. et al. (2001) A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation. Nat Immunol 2:35360.
  • Hogan S.P., Rothenberg M.E., Forbes E., Smart V.E., Matthaei K.I., & Foster P.S. (2004) Chemokines in eosinophil-associated gastrointestinal disorders. Curr Allergy Asthma Rep 4:7482.
  • Hokibara S., Takamoto M., Tominaga A., Takatsu K., & Sugane K. (1997) Marked eosinophilia in interleukin-5 transgenic mice fails to prevent Trichinella spiralis infection. J Parasitol 83:11869.
  • Horie S., Okubo Y., Hossain M. et al. (1997) Interleukin-13 but not interleukin-4 prolongs eosinophil survival and induces eosinophil chemotaxis. Intern Med 36:17985.
  • Horigome K., Bullock E.D., & Johnson E.M. Jr. (1994) Effects of nerve growth factor on rat peritoneal mast cells. Survival promotion and immediate-early gene induction. J Biol Chem 269:2695702.
  • Humbert M., Menz G., Ying S. et al. (1999) The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. Immunol Today 20:52833.
  • Humbles A.A., Lu B., Friend D.S. et al. (2002) The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc Natl Acad Sci USA 99:147984.
  • Humbles A.A., Lloyd C.M., McMillan S.J. et al. (2004) A critical role for eosinophils in allergic airways remodeling. Science 305:17769.
  • Hunt L.W., Frigas E., Butterfield J.H. et al. (2004) Treatment of asthma with nebulized lidocaine: a randomized, placebo-controlled study. J Allergy Clin Immunol 113:8539.
  • Hussain A., Brown P.J., Thwaites B.C., & Hastings A.G. (1994) Eosinophilic endomyocardial disease due to high grade chest wall sarcoma. Thorax 49:10401.
  • Iacono G., Carroccio A., Cavataiio F. et al. (1996) Gastroesophageal reflux and cows milk allergy in infants: a prospective study. J Allergy Clin Immunol 97:8227.
  • Iredale M.J., Wanklyn S.A., Phillips I.P., Krausz T., & Ind P.W. (1994) Non-invasive assessment of bronchial inflammation in asthma: no correlation between eosinophilia of induced sputum and bronchial responsiveness to inhaled hypertonic saline. Clin Exp Allergy 24:9405.
  • Ishihara C., Ochiai K., Kagami M. et al. (1997) Human peripheral eosinophils express functional interferon-gamma receptors (IFNgammaR). Clin Exp Immunol 110:5249.
  • Iwama A., Osawa M., Hirasawa R. et al. (2002) Reciprocal roles for CCAAT/enhancer binding protein (C/EBP) and PU1 transcription factors in Langerhans cell commitment. J Exp Med 195:54758.
  • Jankovic D., Steinfelder S., Kullberg M.C., & Sher A. (2006) Mechanisms underlying helminth-induced Th2 polarization: default, negative or positive pathways? Chem Immunol Allergy 90:6581.
  • Jose P.J., Griffiths-Johnson D.A., Collins P.D. et al. (1994) Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 179:8817.
  • Kane G.C., Pollice M., Kim C.J. et al. (1996) A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings. J Allergy Clin Immunol 97:64654.
  • Kariyawasam H.H., Aizen M., Barkans J., Robinson D.S., & Kay A.B. (2007) Remodelling and airway hyperresponsiveness but not cellular inflammation persist after allergen challenge in asthma. Am J Respir Care Med 175:896904.
  • Kay A.B., Phipps S., & Robinson D.S. (2004) A role for eosinophils in airway remodelling in asthma. Trends Immunol 25:47782.
  • Kelly K.J., Lazenby A.J., Rowe P.C., Yardley J.H., Perman J.A., & Sampson H.A. (1995) Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology 109:150312.
  • Keshavarzian A., Saverymuttu S.H., Tai P.C. et al. (1985) Activated eosinophils in familial eosinophilic gastroenteritis. Gastroenterology 88:10419.
  • Khan S., & Orenstein S.R. (2002) Eosinophilic gastroenteritis: epidemiology, diagnosis and management. Paediatr Drugs 4:56370.
  • Khodoun M.V., Orekhova T., Potter C., Morris S., & Finkelman F.D. (2004) Basophils initiate IL-4 production during a memory T-dependent response. J Exp Med 200:85770.
  • Kim C.K., Koh J.Y., Han T.H., Kim do K., Kim B.I., & Koh Y.Y. (2006) Increased levels of BAL cysteinyl leukotrienes in acute RSV bronchiolitis. Acta Paediatr 95:47985.
  • Kim J.T., Schimming A.W., & Kita H. (1999) Ligation of Fc gamma RII (CD32) pivotally regulates survival of human eosinophils. J Immunol 162:42539.
  • Kincade P.W. (2006) Supplying the demand for granulocytes. Nat Immunol 7:7012.
  • Kips J.C., O'Connor B.J., Langley S.J. et al. (2003) Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study. Am J Respir Crit Care Med 167:16559.
  • Kita H. (1996) The eosinophil: a cytokine-producing cell? J Allergy Clin Immunol 97:88992.
  • Kita H., & Gleich G.J. (1997) Eosinophils and IgE receptors: a continuing controversy. Blood 89:3497501.
  • Kita H., Abu-Ghazaleh R.I., Gleich G.J., & Abraham R.T. (1991) Regulation of Ig-induced eosinophil degranulation by adenosine 3′,5- cyclic monophosphate. J Immunol 146:271218.
  • Kita H., Kaneko M., Bartemes K.R. et al. (1999) Does IgE bind to and activate eosinophils from patients with allergy? J Immunol 162:690111.
  • Klion A.D., & Nutman T.B. (2004) The role of eosinophils in host defense against helminth parasites. J Allergy Clin Immunol 113:307.
  • Klion A.D., Noel P., Akin C. et al. (2003) Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood 101:46606.
  • Klion A.D., Robyn J., Akin C. et al. (2004a) Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. Blood 103:4738.
  • Klion A.D., Law M.A., Noel P., Kim Y.J., Haverty T.P., & Nutman T.B. (2004b) Safety and efficacy of the monoclonal anti-interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndrome. Blood 103:293941.
  • Klion A.D., Bochner B.S., Gleich G.J. et al. (2006) Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol 117:1292302.
  • Knopf P.M., Nutman T.B., & Reasoner J.A. (1977) Schistosoma mansoni resistance to reinfection in the rat. Exp Parasitol 41:7482.
  • Koenderman L., Kuijpers T.W., Blom M., Tool A.T., Roos D., & Verhoeven A.J. (1991) Characteristics of CR3-mediated aggregation in human eosinophils: effect of priming by platelet-activating factor. J Allergy Clin Immunol 87:94754.
  • Kopf M., Brombacher F., Hodgkin P.D. et al. (1996) IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 4:1524.
  • Korenaga M., Hitoshi Y., Yamaguchi N., Sato Y., Takatsu K., & Tada I. (1991) The role of interleukin-5 in protective immunity to Strongyloides venezuelensis infection in mice. Immunology 72:5027.
  • Korsgren M., Erjefalt J.S., Korsgren O., Sundler F., & Persson C.G.A. (1997) Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J Exp Med 185:88592.
  • Kristjansson S., Bjarnarson S.P., Wennergren G. et al. (2005) Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response. J Allergy Clin Immunol 116:80511.
  • Kuijpers T.W., Mul E.P., Blom M. et al. (1993) Freezing adhesion molecules in a state of high-avidity binding blocks eosinophil migration. J Exp Med 178:27984.
  • Kunkel E.J., & Butcher E.C. (2002) Chemokines and the tissuespecific migration of lymphocytes. Immunity 16:14.
  • Lacy P., & Moqbel R. (1997) Eokines: synthesis, storage and release from human eosinophils. Mem Inst Oswaldo Cruz 92 (suppl.):H125H133.
  • Lacy P., & Moqbel R. (2000) Eosinophil cytokines. Chem Immunol 76:13455.
  • Lacy P., Thompson N., & Tian M. (1995) A survey of GTP-binding proteins and other potential key regulators of exocytotic secretion in eosinophils. Apparent absence of rab3 and vesicle fusion protein homologues. J Cell Sci 108:354756.
  • Lacy P., Mahmudi-Azer S., Bablitz B. et al. (1999) Rapid mobilization of intracellularly stored RANTES in response to interferon-γ in human eosinophils. Blood 94:2332.
  • Lacy P., Logan M.R., Bablitz B., & Moqbel R. (2001) Fusion protein vesicle-associated membrane protein 2 is implicated in IFNgamma-induced piecemeal degranulation in human eosinophils from atopic individuals. J Allergy Clin Immunol 107:6718.
  • Lacy P., Abdel Latif D., Steward M., Musat-Marcu S., Man S.F., & Moqbel R. (2003) Divergence of mechanisms regulating respiratory burst in blood and sputum eosinophils and neutrophils from atopic subjects. J Immunol 170:26709.
  • Leckie M.J. (2003) Anti-interleukin-5 monoclonal antibodies: preclinical and clinical evidence in asthma models. Am J Respir Med 2:24559.
  • Leckie M.J., Ten Brinke A., Khan J. et al. (2000) Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356:21448.
  • Lee J., McGarry M., Farmer S. et al. (1997) Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med 185:214356.
  • Lee J.J., & Lee N.A. (2005) Eosinophil degranulation: an evolutionary vestige or a universally destructive effector function? Clin Exp Allergy 35:615.
  • Lee J.J., Dimina D., Macias M.P. et al. (2004) Defining a link with asthma in mice congenitally deficient in eosinophils. Science 305:17736.
  • Le Goff L., Loke P., Ali H.F., Taylor D.W., & Allen J.E. (2000) Interleukin-5 is essential for vaccine-mediated immunity but not innate resistance to a filarial parasite. Infect Immun 68:251317.
  • Lehrer R.I., Szklarek D., Barton A., Ganz T., Hamann K.J., & Gleich G.J. (1989) Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J Immunol 142:442834.
  • Lewis D.M., Lewis J.C., Loegering D.A., & Gleich G.J. (1978) Localization of the guinea pig eosinophil major basic protein to the core of the granule. J Cell Biol 77:70213.
  • Liacouras C.A., Wenner W.J., Brown K., & Ruchelli E. (1998) Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr 26:3805.
  • Logan M.R., Lacy P., Bablitz B., & Moqbel R. (2002) Expression of eosinophil target SNAREs as potential cognate receptors for vesicle-associated membrane protein-2 in exocytosis. J Allergy Clin Immunol 109:299306.
  • Logan M.R., Odemuyiwa S.O., & Moqbel R. (2003) Understanding exocytosis in immune and inflammatory cells: the molecular basis of mediator secretion. J Allergy Clin Immunol 111:92332.
  • Logan M.R., Lacy P., Odemuyiwa S.O. et al. (2006) A critical role for vesicle-associated membrane protein-7 in exocytosis from human eosinophils and neutrophils. Allergy 61:77784.
  • Lopez A.F., Begley C.G., Williamson D.J., Warren D.J., Vadas M.A., & Sanderson C.J. (1986) Murine eosinophil differentiation factor. An eosinophil-specific colony-stimulating factor with activity for human cells. J Exp Med 163:108599.
  • Lopez A.F., Sanderson C.J., Gamble J.R., Campbell H.D., Young I.G., & Vadas M.A. (1988) Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 167:21924.
  • Lucey D.R., Nicholson W.A., & Weller P.F. (1989) Mature human eosinophils have the capacity to express HLA-DR. Proc Natl Acad Sci USA 86:134851.
  • Ma W., Bryce P.J., Humbles A.A. et al. (2002) CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. J Clin Invest 109:6218.
  • McDevitt M.A., Fujiwara Y., Shivdasani R.A., & Orkin S.H. (1997) An upstream DNaseI hypersensitive region of the hematopoieticexpressed transcription factor GATA-1 gene confers developmental specificity in transgenic mice. Proc Natl Acad Sci USA 94:797681.
  • McGrogan M., Simonsen C., Scott R. et al. (1988) Isolation of a complementary DNA clone encoding a precursor to human eosinophil major basic protein. J Exp Med 168:2295308.
  • MacKenzie J.R., Mattes J., Dent L.A., & Foster P.S. (2001) Eosinophils promote allergic disease of the lung by regulating CD4+ Th2lymphocyte function. J Immunol 167:314655.
  • McLaren D.J., McKean J.R., Olsson I., Venges P., & Kay A.B. (1981) Morphological studies on the killing of schistosomula of Schistosoma mansoni by human eosinophil and neutrophil cationic proteins in vitro. Parasite Immunol 3:35973.
  • McNagny K.M., & Graf T. (2002) Making eosinophils through subtle shifts in transcription factor expression. J Exp Med 195:F43F47.
  • McNagny K.M., Sieweke M.H., Doderlein G., Graf T., & Nerlov C. (1998) Regulation of eosinophil-specific gene expression by a C/EBP-Ets complex and GATA-1. EMBO J 17:366980.
  • Maddox D.E., Kephart G.M., Coulam C.B., Butterfield J.H., Benirschke K., & Gleich G.J. (1984) Localization of a molecule immunochemically similar to eosinophil major basic protein in human placenta. J Exp Med 160:2941.
  • Martin J.G., Siddiqui S., & Hassan M. (2006) Immune responses to viral infections: relevance to asthma. Paediatr Respir Rev 7 (suppl. 1):S125S127.
  • Matsumoto K., Schleimer R.P., Saito H., Iikura Y., & Bochner B.S. (1995) Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 86:143743.
  • Matsuyama G., Ochiai K., Ishihara C., Kagami M., Tomioka H., & Koya N. (1998) Heterogeneous expression of tumor necrosis factor-alpha receptors I and II on human peripheral eosinophils. Int Arch Allergy Immunol 117 (suppl. 1):2833.
  • Matthews A.N., Friend D.S., Zimmermann N. et al. (1998) Eotaxin is required for the baseline level of tissue eosinophils. Proc Natl Acad Sci USA 95:62738.
  • Mauser P.J., Pitman A.M., Fernandez X. et al. (1995) Effects of an antibody to interleukin-5 in a monkey model of asthma. Am J Respir Crit Care Med 152:46772.
  • Mawhorter S.D., Kazura J.W., & Boom W.H. (1994) Human eosinophils as antigen-presenting cells: relative efficiency for superantigen- and antigen-induced CD4+ T-cell proliferation. Immunology 81:58491.
  • Mayeno A.N., Curran A.J., Roberts R.L., & Foote C.S. (1989) Eosinophils preferentially use bromide to generate halogenating agents. J Biol Chem 264:56608.
  • Meeusen E.N., & Balic A. (2000) Do eosinophils have a role in the killing of helminth parasites? Parasitol Today 16:95101.
  • Menzies-Gow A., Ying S., Sabroe I. et al. (2002) Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers. J Immunol 169:271218.
  • Metcalf D. (1991) Control of granulocytes and macrophages: molecular, cellular and clinical aspects. Science 254:52933.
  • Miller A.L., Bowlin T.L., & Lukacs N.W. (2004) Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo. J Infect Dis 189:141930.
  • Mishra A., Hogan S.P., Lee J.J., Foster P.S., & Rothenberg M.E. (1999) Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J Clin Invest 103:171927.
  • Mishra A., Hogan S.P., Brandt E.B., & Rothenberg M.E. (2000) Peyer's patch eosinophils: identification, characterization, and regulation by mucosal allergen exposure, interleukin-5, and eotaxin. Blood 96:153844.
  • Mishra A., Hogan S.P., Brandt E.B. et al. (2002) Enterocyte expression of the eotaxin and interleukin-5 transgenes induces compartmentalized dysregulation of eosinophil trafficking. J Biol Chem 277:440612.
  • Monteiro R.C., Hostoffer R.W., Cooper M.D., Bonner J.R., Gartland G.L., & Kubagawa H. (1993) Definition of immunoglobulin-A receptors on eosinophils and their enhanced expression in allergic individuals. J Clin Invest 92:16815.
  • Moon A., & Kleinman R.E. (1995) Allergic gastroenteropathy in children. Ann Allergy Asthma Immunol 74:512.
  • Moqbel R., & Lacy P. (1998) Eosinophil cytokines. In: BusseW.W., HolgateS.T., eds. Inflammatory Mechanisms in Asthma. Marcel Dekker, New York. pp. 22746.
  • Moser R., Fehr J., & Bruijnzeel P.L. (1992) IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. J Immunol 149:14328.
  • Mullock B.M., Smith C.W., Ihrke G. et al. (2000) Syntaxin 7 is localized to late endosome compartments, associates with Vamp 8, and is required for late endosome–lysosome fusion. Mol Biol Cell 11:313753.
  • Munitz A., & Levi-Schaffer F. (2007) Inhibitory receptors on eosinophils: a direct hit to a possible Achilles heel? J Allergy Clin Immunol 119:13827.
  • Munitz A., Bachelet I., Fraenkel S. et al. (2005) 2B4 (CD244) is expressed and functional on human eosinophils. J Immunol 174:11018.
  • Munitz A., Bachelet I., Eliashar R. et al. (2006) CD48 is an allergen and IL-3-induced activation molecule on eosinophils. J Immunol 177:7783.
  • Murphy P.M. (1994) The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol 12:593633.
  • Nagase H., Miyamasu M., Yamaguchi M. et al. (2000) Glucocorticoids preferentially upregulate functional CXCR4 expression in eosinophils. J Allergy Clin Immunol 106:11329.
  • Nagase H., Okugawa S., Ota Y. et al. (2003) Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand. J Immunol 171:397782.
  • Nakajima H., Sano H., Nishimura T., Yoshida S., & Iwamoto I. (1994) Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue. J Exp Med 179:114554.
  • Nakamura H., Luster A.D., Nakamura T. et al. (2001) Variant eotaxin: its effects on the asthma phenotype. J Allergy Clin Immunol 108:94653.
  • Nerlov C., & Graf T. (1998) PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev 12:240312.
  • Nerlov C., McNagny K.M., Doderlein G., Kowenz-Leutz E., & Graf T. (1998) Distinct C/EBP functions are required for eosinophil lineage commitment and maturation. Genes Dev 12:241323.
  • Nishitani H., Okabayashi M., Satomi M., Shimoyama T., & Dohi Y. (1998) Infiltration of peroxidase-producing eosinophils into the lamina propria of patients with ulcerative colitis. J Gastroenterol 33:18995.
  • Nutku E., Soussi Gounni A., Hazcku A. et al. (1999) Stimulation of IL-9 receptors on human eosinophils upregulates IL-5 rceptor mRNA expression. J Allergy Clin Immunol 103:S113.
  • Nutku E., Aizawa H., Hudson S.A., & Bochner B.S. (2003) Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. Blood 101:501420.
  • O'Byrne P.M., Inman M.R., & Parameswaran K. (2001) The trials and tribulations of interleukin-5, eosinophils and allergic asthma. J Allergy Clin Immunol 108:5038.
  • Ochiai K., Ishihara C., & Tomioka H. (1999) Signal transduction through interferon-gamma receptor on human eosinophils. Int Arch Allergy Immunol 118:4436.
  • Odemuyiwa S.O., Ghahary A., Li Y. et al. (2004) Human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxyenase. J Immunol 173:590913.
  • O'Donnell M.C., Ackerman S.J., Gleich G.J., & Thomas L.L. (1983) Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J Exp Med 157:198191.
  • Odze R.D., Wershil B.K., Leichtner A.M., & Antonioli D.A. (1995) Allergic colitis in infants. J Pediatr 126:16370.
  • Ohkawara Y., Lim K.G., Xing Z. et al. (1996) CD40 expression by human peripheral blood eosinophils. J Clin Invest 97:17616.
  • Ohno I., Ohtani H., Nitta Y. et al. (1997) Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Respir Cell Mol Biol 16:21219.
  • Ohshima N., Nagase H., Koshino T. et al. (2002) A functional study on CysLT(1) receptors in human eosinophils. Int Arch Allergy Immunol 129:6775.
  • Okada S., Kita H., George T.J., Gleich G.J., & Leiferman K.M. (1997) Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol 17:51928.
  • Oliveira S.H., Lira S., Martinez A.C., Wiekowski M., Sullivan L., & Lukacs N.W. (2002) Increased responsiveness of murine eosinophils to MIP-1beta (CCL4) and TCA-3 (CCL1) is mediated by their specific receptors, CCR5 and CCR8. J Leukoc Biol 71:101925.
  • Ollerenshaw S.L., & Woolcock A.J. (1992) Characteristics of the inflammation in biopsies from large airways of subjects with asthma and subjects with chronic airflow limitation. Am Rev Respir Dis 145:9227.
  • Onodera K., Takahashi S., Nishimura S. et al. (1997) GATA-1 transcription is controlled by distinct regulatory mechanisms during primitive and definitive erythropoiesis. Proc Natl Acad Sci USA 94:448792.
  • Openshaw P.J., & Tregoning J.S. (2005) Immune responses and disease enhancement during respiratory syncytial virus infection. Clin Microbiol Rev 18:54155.
  • O'Reilly M., Alpert R., Jenkinson S. et al. (2002) Identification of a histamine H4 receptor on human eosinophils: role in eosinophil chemotaxis. J Recept Signal Transduct Res 22:43148.
  • Owen W.F., Rothenberg M.E., Petersen J. et al. (1989) Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome. J Exp Med 170:3438.
  • Oyaizu N., Uemura Y., Izumi H., Morii S., Nishi M., & Hioki K. (1985) Eosinophilic gastroenteritis: immunohistochemical evidence for IgE mast cell-mediated allergy. Acta Pathol Jpn 35:75966.
  • Page S.M., Gleich G.J., Roebuck K.A., & Thomas L.L. (1999) Stimulation of neutrophil interleukin-8 production by eosinophil granule major basic protein. Am J Respir Cell Mol Biol 21:2307.
  • Paumet F., Le Mao J., Martin S. et al. (2000) Soluble NSF attachment protein receptors (SNAREs) in RBL-2H3 mast cells: functional role of syntaxin 4 in exocytosis and identification of a vesicle-associated membrane protein 8-containing secretory compartment. J Immunol 164:58507.
  • Pearce E.J., Kane C., Sun J.J., Taylor J., McKee A.S., & Cervi L. (2004) Th2 response polarization during infection with the helminth parasite Schistosoma mansoni. Immunol Rev 201:11726.
  • Pearlman E., Hall L.R., Higgins A.W. et al. (1998) The role of eosinophils and neutrophils in helminth-induced keratitis. Invest Ophthalmol Vis Sci 39:117682. [Erratum appears in Invest Ophthalmol Vis Sci (1998) 39, 1641.].
  • Pégorier S., Wagner L.A., Gleich G.J., & Pretolani M. (2006) Eosinophil-derived cationic proteins activate the synthesis of remodeling factors by airway epithelial cells. J Immunol 177:48619.
  • Peters M.S., Rodriguez M., & Gleich G.J. (1986) Localization of human eosinophil granule major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin by immunoelectron microscopy. Lab Invest 54:65662.
  • Phillips R.M., Stubbs V.E., Henson M.R., Williams T.J., Pease J.E., & Sabroe I. (2003) Variations in eosinophil chemokine responses: an investigation of CCR1 and CCR3 function, expression in atopy, and identification of a functional CCR1 promoter. J Immunol 170:6190201.
  • Phipps S., Flood-Page P., Menzies-Gow A., Ong Y.E., & Kay A.B. (2004a) Intravenous anti-IL-5 monoclonal antibody reduces eosinophils and tenascin deposition in allergen-challenged human atopic skin. J Invest Dermatol 122:140612.
  • Phipps S., Benyahia F., Ou T.T., Barkans J., Robinson D.S., & Kay A.B. (2004b) Acute allergen-induced airway remodeling in atopic asthma. Am J Respir Cell Mol Biol 31:62632.
  • Phipps S., Lam C.E., Mahalingam S. et al. (2007) Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus. Blood 110:157886.
  • Piedra P.A. (2003) Clinical experience with respiratory syncytial virus vaccines. Pediatr Infect Dis J 22:S94S99.
  • Piliponsky A.M., Pickholtz D., Gleich G.J., & Levi-Schaffer F. (2001) Human eosinophils induce histamine release from antigenactivated rat peritoneal mast cells: a possible role for mast cells in late-phase allergic reactions. J Allergy Clin Immunol 107:9931000.
  • Piliponsky A., Gleich G., Bar I., & Levi-Schaffer F. (2002) Effects of eosinophils on mast cells: a new pathway for the perpetuation of allergic inflammation. Mol Immunol 38:1369.
  • Plager D.A., Loegering D.A., Checkel J.L. et al. (2006) Major basic protein homolog (MBP2): a specific human eosinophil marker. J Immunol 177:73405.
  • Plotz S.G., Lentschat A., Behrendt H. et al. (2001) The interaction of human peripheral blood eosinophils with bacterial lipopolysaccharide is CD14 dependent. Blood 97:23541.
  • Polgar J., Chung S.H., & Reed G.L. (2002) Vesicle-associated membrane protein 3 (VAMP-3) and VAMP-8 are present in human platelets and are required for granule secretion. Blood 100:10813.
  • Ponath P.D., Qin S., Post T.W. et al. (1996) Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med 183:243748.
  • Pope S.M., Fulkerson P.C., Blanchard C. et al. (2005a) Identification of a cooperative mechanism involving interleukin-13 and eotaxin-2 in experimental allergic lung inflammation. J Biol Chem 280:1395261.
  • Pope S.M., Zimmermann N., Stringer K.F., Karow M.L., & Rothenberg M.E. (2005b) The eotaxin chemokines and CCR3 are fundamental regulators of allergen-induced pulmonary eosinophilia. J Immunol 175:534150.
  • Popken-Harris P., Checkel J., Loegering D. et al. (1998) Regulation and processing of a precursor form of eosinophil granule major basic protein (ProMBP) in differentiating eosinophils. Blood 92:62331.
  • Powell W.S., Chung D., & Gravel S. (1995) 5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of human eosinophil migration. J Immunol 154:412332.
  • Pretolani M., Ruffie C., Lapa e Silva J.R., Joseph D., Lobb R.R., & Vargaftig B.B. (1994) Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways. J Exp Med 180:795805.
  • Rand T.H., Lopez A.F., Gamble J.R., & Vadas M.A. (1988) Nedocromil sodium and cromolyn (sodium cromoglycate) selectively inhibit antibody-dependent granulocyte-mediated cytotoxicity. Int Arch Allergy Appl Immunol 87:1518.
  • Rand T.H., Silberstein D.S., Kornfeld H., & Weller P.F. (1991) Human eosinophils express functional interleukin 2 receptors. J Clin Invest 88:82532.
  • Randolph A.G., & Wang E.E. (1996) Ribavirin for respiratory synctial virus lower respiratory tract infection. A systemic overview. Arch Pediatr Adolesc Med 150:9427.
  • Rankin S.M., Conroy D.M., & Williams T.J. (2000) Eotaxin and eosinophil recruitment: implications for human disease. Mol Med Today 6:207.
  • Rao S.K., Huynh C., Proux-Gillardeaux V., Galli T., & Andrews N.W. (2004) Identification of SNAREs involved in synaptotagmin VII-regulated lysosomal exocytosis. J Biol Chem 279:204719.
  • Ravichandran V., Chawla A., & Roche P.A. (1996) Identification of a novel syntaxin- and synaptobrevin/VAMP-binding protein, SNAP-23, expressed in non-neuronal tissues. J Biol Chem 271:133003.
  • Redier H., Chanez P., De V.C. et al. (1992) Inhibitory effect of cetirizine on the bronchial eosinophil recruitment induced by allergen inhalation challenge in allergic patients with asthma. J Allergy Clin Immunol 90:21524.
  • Reiman R.M., Thompson R.W., Feng C.G. et al. (2006) Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity. Infect Immun 74:14719.
  • Rohrbach M.S., Wheatley C.L., Slifman N.R., & Gleich G.J. (1990) Activation of platelets by eosinophil granule proteins. J Exp Med 172:12714.
  • Romano M., Patriarca P., Melo C., Baralle F.E., & Dri P. (1994) Hereditary eosinophil peroxidase deficiency: immunochemical and spectroscopic studies and evidence for a compound heterozygosity of the defect. Proc Natl Acad Sci USA 91:12496500.
  • Rosenberg H.F., & Domachowske J.B. (2001) Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens. J Leukoc Biol 70:6918.
  • Rosenberg H.F., Ackerman S.J., & Tenen D.G. (1989) Human eosinophil cationic protein. Molecular cloning of a cytotoxin and helminthotoxin with ribonuclease activity. J Exp Med 170:16376.
  • Rosenberg H.F., Dyer K.D., Tiffany H.L., & Gonzalez M. (1995) Rapid evolution of a unique family of primate ribonuclease genes. Nat Genet 10:21923.
  • Rosenberg H.F., Bonville C.A., Easton A.J., & Domachowske J.B. (2005) The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention. Pharmacol Ther 105:16.
  • Rossetto O., Gorza L., Schiavo G., Schiavo N., Scheller R.H., & Montecucco C. (1996) VAMP/synaptobrevin isoforms 1 and 2 are widely and differentially expressed in nonneuronal tissues. J Cell Biol 132:16779.
  • Rothenberg M.E. (1998) Eosinophilia. N Engl J Med 338:1592600.
  • Rothenberg M.E., & Hogan S.P. (2006) The eosinophil. Annu Rev Immunol 24:14774.
  • Rothenberg M.E., Pomerantz J.L., Owen W.F. et al. (1988) Characterization of a human eosinophil proteoglycan, and augmentation of its biosynthesis and size by interleukin 3, interleukin 5, and granulocyte/macrophage colony stimulating factor. J Biol Chem 263:139018.
  • Rothenberg M.E., Luster A.D., Lilly C.M., Drazen J.M., & Leder P. (1995) Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung. J Exp Med 181:121116.
  • Rothenberg M.E., MacLean J.A., Pearlman E., Luster A.D., & Leder P. (1997) Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J Exp Med 185:78590.
  • Rothenberg M.E., Mishra A., Brandt E.B., & Hogan S.P. (2001a) Gastrointestinal eosinophils in health and disease. Adv Immunol 78:291328.
  • Rothenberg M.E., Mishra A., Collins M.H., & Putnam P.E. (2001b) Pathogenesis and clinical features of eosinophilic esophagitis. J Allergy Clin Immunol 108:8914.
  • Rothenberg M.E., Mishra A., Brandt E.B., & Hogan S.P. (2001c) Gastrointestinal eosinophils. Immunol Rev 179:13955.
  • Roufosse F., Cogan E., & Goldman M. (2003) The hypereosinophilic syndrome revisited. Annu Rev Med 54:16984.
  • Saavedra-Delgado A.M., & Metcalfe D.D. (1985) Interactions between food antigens and the immune system in the pathogenesis of gastrointestinal diseases. Ann Allergy 55:694702.
  • Sabroe I., Jones E.C., Usher L.R., Whyte M.K., & Dower S.K. (2002) Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. J Immunol 168:470110.
  • Saito T., Deskin R.W., Casola A. et al. (1997) Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells. J Infect Dis 175:497504.
  • Sampson H.A. (1997) Food allergy. JAMA 278:188894.
  • Sampson H.A. (1999) Food allergy: Part 1: immunopathogenesis and clinical disorders. J Allergy Clin Immunol 103:71728.
  • Sanderson C.J. (1992) Interleukin-5, eosinophils, and disease. Blood 79:31019.
  • Sarin S.K., Malhotra V., Sen Gupta S., Karol A., Gaur S.K., & Anand B.S. (1978) Significance of eosinophil and mast cell counts in rectal mucosa in ulcerative colitis. A prospective controlled study. Dig Dis Sci 32:3637.
  • Sasaki O., Sugaya H., Ishida K., & Yoshimura K. (1993) Ablation of eosinophils with anti-IL-5 antibody enhances the survival of intracranial worms of Angiostrongylus cantonensis in the mouse. Parasite Immunol 15:34954.
  • Schaller J.L., & Burkland G.A. (2001) Case report: rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate. MedGenMed 3:9.
  • Schaller M., Hogaboam C.M., Lukacs N., & Kunkel E.J. (2006) Respiratory viral infections drive chemokine expression and excerbate the asthmatic response. J Allergy Clin Immunol 118:295302.
  • Schleimer R.P., & Bochner B.S. (1994) The effect of glucocorticoids on human eosinophils. J Allergy Clin Immunol 94:120213.
  • Schwingshackl A., Duszyk M., Brown N., & Moqbel R. (1999) Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-α. J Allergy Clin Immunol 104:9839.
  • Scudamore H.H., Phillips S.F., Swedlund H.A., & Gleich G.J. (1982) Food allergy manifested by eosinophilia, elevated immunoglobulin E level, and protein-losing enteropathy: the syndrome of allergic gastroenteropathy. J Allergy Clin Immunol 70:12936.
  • Sedgwick J.B., Calhoun W.J., Vrtis R.F., Bates M.E., McAllister P.K., & Busse W.W. (1992) Comparison of airway and blood eosinophil function after in vivo antigen challenge. J Immunol 149:371018.
  • Seminario M.C., Saini S.S., MacGlashan D.W. Jr., & Bochner B.S. (1999) Intracellular expression and release of Fc epsilon RI alpha by human eosinophils. J Immunol 162:6893900.
  • Shen Z., Wu W., & Hazen S.L. (2000) Activated leukocytes oxidatively damage DNA RNA, and the nucleotide pool through halide-dependent formation of hydroxyl radical. Biochemistry 39:547482.
  • Shenoy N.G., Gleich G.J., & Thomas L.L. (2003) Eosinophil major basic protein stimulates neutrophil superoxide production by a class IA phosphoinositide 3-kinase and protein kinase C-zetadependent pathway. J Immunol 171:373441.
  • Sher A., Coffman R.L., Hieny S., & Cheever A.W. (1990a) Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse. J Immunol 145:391116.
  • Sher A., Coffman R.L., Hieny S., Scott P., & Cheever A.W. (1990b) Interleukin-5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. Proc Natl Acad Sci USA 87:615.
  • Sherman M.P., & Cox K.L. (1982) Neonatal eosinophilic colitis. J Pediatr 100:5879.
  • Shi H. (2004) Eosinophils function as antigen-presenting cells. J Leukoc Biol 76:5207.
  • Shi H.Z., Humbles A., Gerard C., Jin Z., & Weller P.F. (2000) Lymph node trafficking and antigen presentation by endobronchial eosinophils. J Clin Invest 105:94553.
  • Shi H.Z., Xiao C.Q., Li C.Q. et al. (2004) Endobronchial eosinophils preferentially stimulate T helper cell type 2 responses. Allergy 59:42835.
  • Shinagawa K., & Kojima M. (2003) Mouse model of airway remodeling: strain differences. Am J Respir Crit Care Med 168:95967.
  • Shinkai A., Yoshisue H., Koike M. et al. (1999) A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. J Immunol 163:160210.
  • Shinkai K., Mohrs M., & Locksley R.M. (2002) Helper T cells regulate type-2 innate immunity in vivo. Nature 420:8259.
  • Shiraishi Y., Asano K., Nakajima T. et al. (2005) Prostaglandin D2-induced eosinophilic airway inflammation is mediated by CRTH2 receptor. J Pharmacol Exp Ther 312:95460.
  • Sihra B.S., Kon O.M., Durham S.R., Walker S., Barnes N.C., & Kay A.B. (1997) Effect of cyclosporin A on the allergen-induced late asthmatic reaction. Thorax 52:44752.
  • Simon H.U., Plotz S.G., Dummer R., & Blaser K. (1999) Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med 341:111220.
  • Singh A.M., Moore P.E., Gern J.E., Lemanske R.F. Jr., & Hartert T.V. (2007) Bronchiolitis to asthma. A review and call for studies of gene–viral interactions in asthma causation. Am J Crit Care Med 175:10819.
  • Slifman N.R., Loegering D.A., McKean D.J., & Gleich G.J. (1986) Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein. J Immunol 137:291317.
  • Slungaard A., & Mahoney J.R. (1991) Thiocyanate is the major substrate for eosinophil peroxidase in physiologic fluids. Implications for cytotoxicity. J Biol Chem 266:490310.
  • Snyman J.R., Sommers D.K., Gregorowski M.D., & Boraine H. (1992) Effect of cetirizine, ketotifen and chlorpheniramine on the dynamics of the cutaneous hypersensitivity reaction: a comparative study. Eur J Clin Pharmacol 42:35962.
  • Sollner T., Whiteheart S.W., Brunner M. et al. (1993) SNAP receptors implicated in vesicle targeting and fusion. Nature 362:31824.
  • Solomon A., Aloe L., Pe'er J., Frucht-Pery J., Bonini S., & Levi-Schaffer F. (1998) Nerve growth factor is preformed in and activates human peripheral blood eosinophils. J Allergy Clin Immunol 102:45460.
  • Someya A., Nishijima K., Nunoi H., Irie S., & Nagaoka I. (1997) Study on the superoxide-producing enzyme of eosinophils and neutrophils: comparison of the NADPH oxidase components. Arch Biochem Biophys 345:20713.
  • Spergel J.M., Beausoleil J.L., Mascarenhas M., & Liacouras C.A. (2002) The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Immunol 109:3638.
  • Spry C.J.F. (1988); Eosinophils. A Comprehensive Review and Guide to the Scientific and Medical Literature. Oxford Medical Publications, Oxford.
  • Sriramarao P., Von Andrian U.H., Butcher E.C., Bourdon M.A., & Broide D.H. (1994) L-selectin and very late antigen-4 integrin promote eosinophil rolling at physiological shear rates in vivo. J Immunol 153:423846.
  • Steegmaier M., Klumperman J., Foletti D.L., Yoo J.S., & Scheller R.H. (1999) Vesicle-associated membrane protein 4 is implicated in trans-Golgi network vesicle trafficking. Mol Biol Cell 10:195772.
  • Stein M.L., Collins M.H., Villanueva J.M. et al. (2006) Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol 118:131219.
  • Stellato C., Matsukura S., Fal A. et al. (1999) Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide. J Immunol 163:562432.
  • Sturrock R.F., Kimani R., Cottrell B.J. et al. (1983) Observations on possible immunity to reinfection among Kenyan schoolchildren after treatment for Schistosoma mansoni. Trans R Soc Trop Med Hyg 77:36371.
  • Sturrock R.F., Kariuki H.C., Thiongo F.W. et al. (1996) Schistosomiasis mansoni in Kenya: relationship between infection and anaemia in schoolchildren at the community level. Trans R Soc Trop Med Hyg 90:4854.
  • Sullivan S.K., McGrath D.A., Liao F., Boehme S.A., Farber J.M., & Bacon K.B. (1999) MIP-3alpha induces human eosinophil migration and activation of the mitogen-activated protein kinases (p42/p44 MAPK). J Leukoc Biol 66:67482.
  • Sutton R.B., Fasshauer D., Jahn R., & Brunger A.T. (1998) Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 A resolution. Nature 395:34753.
  • Swartz J.M., Dyer K.D., Cheever A.W. et al. (2006) Schistosoma mansoni infection in eosinophil lineage-ablated mice. Blood 108:24207.
  • Symon F.A., Lawrence M.B., Williamson M.L., Walsh G.M., Watson S.R., & Wardlaw A.J. (1996) Functional and structural characterization of the eosinophil P-selectin ligand. J Immunol 157:171119.
  • Tachimoto H., & Bochner B.S. (2000) The surface phenotype of human eosinophils. Chem Immunol 76:4562.
  • Tachimoto H., Ebisawa M., & Bochner B.S. (2002) Cross-talk between integrins and chemokines that influences eosinophil adhesion and migration. Int Arch Allergy Immunol 128 (suppl. 1):1820.
  • Takamoto M., Ovington K.S., Behm C.A., Sugane K., Young I.G., & Matthaei K.I. (1997) Eosinophilia, parasite burden and lung damage in Toxocara canis infection in C57Bl/6 mice genetically deficient in IL-5. Immunology 90:51117.
  • Takatsu K., Takaki S., & Hitoshi Y. (1994) Interleukin-5 and its receptor system: implications in the immune system and inflammation. Adv Immunol 57:4590.
  • Tamura N., Ishii N., Nakazawa M. et al. (1996) Requirement of CD80 and CD86 molecules for antigen presentation by eosinophils. Scand J Immunol 44:22938.
  • Tanaka H., Komai M., Nagao K. et al. (2004) Role of interleukin-5 and eosinophils in allergen-induced airway remodeling in mice. Am J Respir Cell Mol Biol 31:628.
  • Tatar M., Petriskova J., Zucha J. et al. (2005) Induced sputum eosinophils, bronchial reactivity, and cough sensitivity in subjetcs with allergic rhinitis. J Physiol Pharmacol 56 (suppl. 4):22736.
  • Ten R.M., Pease L.R., McKean D.J., Bell M.P., & Gleich G.J. (1989) Molecular cloning of the human eosinophil peroxidase. Evidence for the existence of a peroxidase multigene family. J Exp Med 169:175769.
  • Tenen D.G., Hromas R., Licht J.D., & Zhang D.E. (1997) Transcription factors, normal myeloid development and leukemia. Blood 90:489519.
  • Thivierge M., Doty M., Johnson J., Stankova J., & Rola-Pleszczynski M. (2000) IL-5 up-regulates cysteinyl leukotriene 1 receptor expression in HL-60 cells differentiated into eosinophils. J Immunol 165:52216.
  • Thomas E.L., Bozeman P.M., Jefferson M.M., & King C.C. (1995) Oxidation of bromide by the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase. Formation of bromamines. J Biol Chem 270:290613.
  • Throsby M., Herbelin A., Pleau J.M., & Dardenne M. (2000) CD11c+ eosinophils in the murine thymus: developmental regulation and recruitment upon MHC class I-restricted thymocyte deletion. J Immunol 165:196575.
  • Tominaga A., Takaki S., Koyama N. et al. (1991) Transgenic mice expressing a B cell growth and differentiation factor (interleukin 5) develop eosinophilia and autoantibody production. J Exp Med 173:42939.
  • Tong J., Bandulwaia H.S., Clay B.S. et al. (2006) Fas-positive T cells regulate the resolution of airway inflammation in murine model of asthma. J Exp Med 203:117384.
  • Torpier G., Colombel J.F., Mathieu-Chandelier C. et al. (1988) Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein. Clin Exp Immunol 74:4048.
  • Tripp R.A. (2004) Pathogenesis of respiratory syncytial virus infection. Viral Immunol 17:16581.
  • Uchida D.A., Ackerman S.J., Coyle A.J. et al. (1993) The effect of human eosinophil granule major basic protein on airway responsiveness in the rat in vivo. A comparison with polycations. Am Rev Respir Dis 147:9828.
  • Vadas M., Lopez A., Gamble J. et al. (1994) Cytokines and allergy. J Allergy Clin Immunol 94:128993.
  • Van Dijk T.B., Caldenhoven E., Raaijmakers J.A., Lammers J.W., Koenderman L., & De Groot R.P. (1998) The role of transcription factor PU1 in the activity of the intronic enhancer of the eosinophil-derived neurotoxin (RNS2) gene. Blood 91:212632.
  • Van Rijt L.S., Vos N., Hijdra D., De Vries V.C., Hoogsteden H.C., & Lambrecht B.N. (2003) Airways eosinophils accumulate in the mediastinal lymph nodes but lack antigen-presenting potential for naive T-cells. J Immunol 171:33728.
  • Voehringer D., Shinkai K., & Locksley R.M. (2004) Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity 20:26777.
  • Von Andrian U.H., & Engelhardt B. (2003) Alpha4 integrins as therapeutic targets in autoimmune disease. N Engl J Med 348:6872.
  • Wallen N., Kita H., Weiler D., & Gleich G.J. (1991) Glucocorticoids inhibit cytokine-mediated eosinophil survival. J Immunol 147:34905.
  • Walsh G.M. (2001) Eosinophil granule proteins and their role in disease. Curr Opin Hematol 8:2833.
  • Walsh G.M., Hartnell A., Moqbel R. et al. (1990) Receptor expression and functional status of cultured human eosinophils derivedfrom umbilical cord blood mononuclear cells. Blood 76:10511.
  • Walsh G.M., Williamson M.L., Symon F.A., Willars G.B., & Wardlaw A.J. (1996) Ligation of CD69 induces apoptosis and cell death in human eosinophils cultured with granulocyte-macrophage colonystimulating factor. Blood 87:281521.
  • Walsh R.E., & Gaginella T.S. (1991) The eosinophil in inflammatory bowel disease. Scand J Gastronenterol 26:121724.
  • Walsh S.V., Antonioli D.A., Goldman H. et al. (1999) Allergic esophagitis in children: a clinicopathological entity. Am J Surg Pathol 23:3906.
  • Wang H., Tan X., Chang H., Huang W., Gonzalez-Crussi F., & Hsueh W. (1999) Platelet-activating factor receptor mRNA is localized in eosinophils and epithelial cells in rat small intestine: regulation by dexamethasone and gut flora. Immunology 97:44754.
  • Wang J., & Slungaard A. (2006) Role of eosinophil peroxidase in host defense and disease pathology. Arch Biochem Biophys 445:25660.
  • Ward D.M., Pevsner J., Scullion M.A., Vaughn M., & Kaplan J. (2000) Syntaxin 7 and VAMP-7 are soluble N-ethylmaleimidesensitive factor attachment protein receptors required for late endosome–lysosome and homotypic lysosome fusion in alveolar macrophages. Mol Biol Cell 11:232733.
  • Wardlaw A.J. (1999) Molecular basis for selective eosinophil trafficking in asthma: a multistep paradigm. J Allergy Clin Immunol 104:91726.
  • Wardlaw A.J. (2000) The role of adhesion in eosinophil function. Chem Immunol 78:93111.
  • Wardlaw A.J., Walsh G.M., & Symon F.A. (1994) Mechanisms of eosinophil and basophil migration. Allergy 49:797807.
  • Wasmoen T.L., Bell M.P., Loegering D.A., Gleich G.J., Prendergast F.G., & McKean D.J. (1988) Biochemical and amino acid sequence analysis of human eosinophil granule major basic protein. J Biol Chem 263:1255963.
  • Weg V.B., Williams T.J., Lobb R.R., & Nourshargh S. (1993) A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo. J Exp Med 177:5616.
  • Wegner C.D., Gundel R.H., Reilly P., Haynes N., Letts L.G., & Rothlein R. (1990) Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 247:4569.
  • Weigmann M., Goggel R., Sei S. et al. (2007) Effect of a low molecular weight CCR-3 antagonist on chronic experimental asthma. Am J Respir Cell Mol Biol 36:617.
  • Weiler J.M., Edens R.E., & Gleich G.J. (1992) Eosinophil granule cationic proteins regulate complement. I. Activity on the alternative pathway. J Immunol 149:6438.
  • Weiler J.M., Edens R.E., Bell C.S., & Gleich G.J. (1995) Eosinophil granule cationic proteins regulate the classical pathway of complement. Immunology 84:21319.
  • Weiss S.J., Test S.T., Eckmann C.M., Roos D., & Regiani S. (1986) Brominating oxidants generated by human eosinophils. Science 234:2003.
  • Weller P.F. (1994) Eosinophils: structure and functions. Curr Opin Immunol 6:8590.
  • Weller P.F., Rand T.H., Barrett T., Elovic A., Wong D.T., & Finberg R.W. (1993) Accessory cell function of human eosinophils. HLADR-dependent, MHC-restricted antigen-presentation and IL-1 alpha expression. J Immunol 150:255462.
  • Wiehler S., Cuvelier S.L., Chakrabarti S., & Patel K.D. (2004) p38 MAP kinase regulates rapid matrix metalloproteinase-9 release from eosinophils. Biochem Biophys Res Commun 315:46370.
  • Winter H.S., Madara J.L., Stafford R.J., Grand R.J., Quinlan J.E., & Goldman H. (1982) Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology 83:81823.
  • Woerly G., Roger N., Loiseau S., Dombrowicz D., Capron A., & Capron M. (1999) Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma): inhibition by immunoglobulin A complexes. J Exp Med 190:48795.
  • Wynn T.A., Thompson R.W., Cheever A.W., & Mentink-Kane M. (2004) Immunopathogenesis of schistosomiasis. Immunol Rev 201:15667.
  • Yamada Y., Rothenberg M.E., Lee A.W. et al. (2006) The FIP1L1–PDGFRA fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)/chronic eosinophilic leukemia (CEL)-like disease. Blood 107:40719.
  • Yamanaka R., Barlow C., Lekstrom-Himes J. et al. (1997) Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. Proc Natl Acad Sci USA 94:1318792.
  • Ying S., Barata L.T., Meng Q. et al. (1998) High-affinity immunoglobulin E receptor (Fc epsilon RI)-bearing eosinophils, mast cells, macrophages and Langerhans' cells in allergen-induced late-phase cutaneous reactions in atopic subjects. Immunology 93:2818.
  • Yoshida T., Naganuma T., Niizawa M., Kakizaki Y., Zeniya A., & Masamune O. (1995) [A case of eosinophilic gastroenteritis accompanied by perimyocarditis, which was strongly suspected.]. Nippon Shokakibyo Gakkai Zasshi 92:11838.
  • Yoshida T., Ikuta K., Sugaya H. et al. (1996) Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5Ra-deficient mice. Immnity 4:48394.
  • You D., Becnel D., Wang K., Ripple M., Daly M., & Cormier S.A. (2006) Exposure of neonates to respiratory syncytial virus is critical in determining subsequent airway responses in adults. Respir Res 7:107.
  • Young J.D., Peterson C.G., Venge P., & Cohn Z.A. (1986) Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature 321:61316.
  • Yu C., Cantor A.B., Yang H. et al. (2002) Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J Exp Med 195:138795.
  • Yuan Q., Austen K.F., Friend D.S., Heidtman M., & Boyce J.A. (1997) Human peripheral blood eosinophils express a functional c-kit receptor for stem cell factor that stimulates very late antigen 4 (VLA-4)-mediated cell adhesion to fibronectin and vascular cell adhesion molecule 1 (VCAM-1). J Exp Med 186:31323.
  • Zeck-Kapp G., & Kapp A. (1995) Subcellular mechanisms of eosinophil degranulation: the role of RANTES, interleukin-5 and tumor necrosis factor-alpha. Int Arch Allergy Immunol 107:345.
  • Zeck-Kapp G., Czech W., & Kapp A. (1994) TNF alpha-induced activation of eosinophil oxidative metabolism and morphology: comparison with IL-5. Exp Dermatol 3:17688.
  • Zeng Q., Subramaniam V.N., Wong S.H. et al. (1998) A novel synaptobrevin/VAMP homologous protein (VAMP5) is increased during in vitro myogenesis and present in the plasma membrane. Mol Biol Cell 9:242337.
  • Zhang D.E., Zhang P., Wang N.D., Hetherington C.J., Darlington G.J., & Tenen D.G. (1997) Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc Natl Acad Sci USA 94:56974.
  • Zhao J., Takamura M., Yamaoka A., Odajima Y., & Iikura Y. (2002) Altered eosinophil levels as a result of viral infection in asthma exacerbation in childhood. Pediatr Allergy Immunol 13:4750.
  • Zheutlin L.M., Ackerman S.J., Gleich G.J., & Thomas L.L. (1984) Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins. J Immunol 133:21805.
  • Zhu J., & Emerson S.G. (2002) Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene 21:3295313.
  • Zhu Z., Zheng T., Homer R.J. et al. (2004) Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science 304:167882.
  • Zimmermann N., Daugherty B.L., Kavanaugh J.L., El-Awar F.Y., Moulton E.A., & Rothenberg M.E. (2000a) Analysis of the CC chemokine receptor 3′ gene reveals a complex 5′ exon organization, a functional role for untranslated exon 1, and a broadly active promoter with eosinophil-selective elements. Blood 96:234654.
  • Zimmermann N., Hogan S.P., Mishra A. et al. (2000b) Murine eotaxin-2: a constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression. J Immunol 165:583946.
  • Zimmermann N., Hershey G.K., Foster P.S., & Rothenberg M.E. (2003) Chemokines in asthma: cooperative interaction between chemokines and IL-13. J Allergy Clin Immunol 111:22742.
  • Zinchuk O., Fukushima A., Zinchuk V., Fukata K., & Ueno H. (2005) Direct action of platelet activating factor (PAF) induces eosinophil accumulation and enhances expression of PAF receptors in conjunctivitis. Mol Vis 11:11423.